Reasons why Baxter International Inc.’s (NYSE:BAX) fundamentals are futile

In yesterday’s Wall Street session, Baxter International Inc. (NYSE:BAX) shares traded at $35.43, up 0.54% from the previous session.

BAX stock price is now -12.94% away from the 50-day moving average and -8.85% away from the 200-day moving average. The market capitalization of the company currently stands at $18.05B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target maintained at $40, TD Cowen recently Downgraded its rating from Buy to Hold for Baxter International Inc. (NYSE: BAX)., while ‘UBS’ rates the stock as ‘Neutral’

In other news, Mason Jeanne K, EVP, Chief HR Officer sold 64,488 shares of the company’s stock on Mar 01 ’24. The stock was sold for $2,618,858 at an average price of $40.61. Upon completion of the transaction, the EVP, Chief HR Officer now directly owns 142,290 shares in the company, valued at $5.04 million. A total of 0.71% of the company’s stock is owned by insiders.

During the past 12 months, Baxter International Inc. has had a low of $31.01 and a high of $50.21. As of last week, the company has a debt-to-equity ratio of 1.73, a current ratio of 1.48, and a quick ratio of 1.01.

According to the Medical Instruments & Supplies Company, earnings per share came in at 0.55, missing analysts’ expectations of 0.61 by -0.06. This compares to $0.09 EPS in the same period last year. The net profit margin was -1.56% and return on equity was -0.54% for BAX. The company reported revenue of $3.59 billion for the quarter, compared to $3.51 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 2.25 percent. For the current quarter, analysts expect BAX to generate $3.75B in revenue.

Related Posts